This evidence is supported by identification of additional IL-7Rα gain-of-function mutations in T-ALL patients that lead to constitutive IL-7 independent receptor activation or else increased activation of the receptor resulting in increased IL-7 response (53, 54). Here, IL7R is linked to acute lymphoblastic leukemia.